cupric chloride has been researched along with Astrocytoma, Grade IV in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amato, R; Bianco, C; Calabria, F; Cascini, GL; Catalogna, G; D'Antona, L; Dattilo, V; Gangemi, V; Musumeci, F; Perrotti, N; Schenone, S; Talarico, C | 1 |
| Chen, X; Guo, J; Huang, X; Jacobson, O; Kiesewetter, DO; Liu, D; Niu, G; Sun, S; Sun, X; Szajek, LP; Wang, Y; Yan, X; Zhu, W | 1 |
2 other study(ies) available for cupric chloride and Astrocytoma, Grade IV
| Article | Year |
|---|---|
The SGK1 Kinase Inhibitor SI113 Sensitizes Theranostic Effects of the 64CuCl2 in Human Glioblastoma Multiforme Cells.
Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Copper; Cyclin-Dependent Kinase Inhibitor p21; Drug Synergism; Glioblastoma; Humans; Immediate-Early Proteins; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Radiation, Ionizing; Signal Transduction; Tumor Suppressor Protein p53 | 2017 |
Chelator-free (64)Cu-integrated gold nanomaterials for positron emission tomography imaging guided photothermal cancer therapy.
Topics: Animals; Cell Line, Tumor; Copper; Copper Radioisotopes; Glioblastoma; Gold; Humans; Mice; Nanostructures; Nanotubes; Oligopeptides; Oxidation-Reduction; Phototherapy; Polyethylene Glycols; Positron-Emission Tomography; Tissue Distribution | 2014 |